Page last updated: 2024-08-23

etoposide and Intellectual Disability

etoposide has been researched along with Intellectual Disability in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Abe, K; Dowsett, L; Hutchins, K; Wada, R1
Fukami, T; Nitta, N; Nozaki, K1
Jereb, B; Macedoni-Luksic, M; Todorovski, L1
Finlay, JL; McElwain, M; Packer, RJ; Pons, MA; Puccetti, D; Walker, RW1

Reviews

1 review(s) available for etoposide and Intellectual Disability

ArticleYear
Germinoma in two brothers: case report.
    Neurologia medico-chirurgica, 2013, Volume: 53, Issue:10

    Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Craniotomy; Dwarfism; Etoposide; Family Health; Germinoma; Humans; Hydrocephalus; Hypothyroidism; Intellectual Disability; Male; Siblings; Supratentorial Neoplasms; Tectum Mesencephali; Ventriculoperitoneal Shunt; Vision Disorders; Young Adult

2013

Trials

1 trial(s) available for etoposide and Intellectual Disability

ArticleYear
Chemotherapy with vincristine (VCR) and etoposide (VP-16) in children with low-grade astrocytoma.
    Journal of neuro-oncology, 1992, Volume: 14, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Astrocytoma; Brain Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Etoposide; Female; Growth Disorders; Hematologic Diseases; Humans; Infant; Intellectual Disability; Male; Neoplasm Recurrence, Local; Neoplasms, Multiple Primary; Nervous System Diseases; Radiation Injuries; Remission Induction; Salvage Therapy; Treatment Outcome; Vincristine

1992

Other Studies

2 other study(ies) available for etoposide and Intellectual Disability

ArticleYear
A pediatric case of acute myeloid leukemia with KMT2A gene rearrangement t(10;11) and 16p11.2 microdeletion syndrome.
    Pediatric blood & cancer, 2021, Volume: 68, Issue:2

    Topics: Antineoplastic Agents; Autistic Disorder; Child; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 16; Cytarabine; Daunorubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Histone-Lysine N-Methyltransferase; Humans; Intellectual Disability; Leukemia, Myeloid, Acute; Mitogen-Activated Protein Kinase 3; Myeloid-Lymphoid Leukemia Protein; Vault Ribonucleoprotein Particles

2021
Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.
    Pediatric hematology and oncology, 2003, Volume: 20, Issue:2

    Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Atrophy; Brain; Brain Damage, Chronic; Brain Neoplasms; Calcinosis; Child; Child, Preschool; Cisplatin; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Disabled Children; Epilepsy; Etoposide; Female; Humans; Hydrocephalus; Infant; Intellectual Disability; Learning Disabilities; Lomustine; Magnetic Resonance Imaging; Male; Methotrexate; Movement Disorders; Neoplasm Recurrence, Local; Prevalence; Procarbazine; Radiation Injuries; Slovenia; Survivors; Tomography, X-Ray Computed; Unemployment; Vincristine; Vision Disorders

2003